We hypothesize that elevated CD8+ T-cell responses are, in part, because PLWH with a history of immune dysfunction were eligible to receive a higher (100 μg) third dose of mRNA-1273, though this would not explain our observations after the second dose. This evidence concerns the gene CD8A and immune system disorder.